NO960309D0 - Agonists and antagonists of human interleukin-10 - Google Patents

Agonists and antagonists of human interleukin-10

Info

Publication number
NO960309D0
NO960309D0 NO960309A NO960309A NO960309D0 NO 960309 D0 NO960309 D0 NO 960309D0 NO 960309 A NO960309 A NO 960309A NO 960309 A NO960309 A NO 960309A NO 960309 D0 NO960309 D0 NO 960309D0
Authority
NO
Norway
Prior art keywords
agonists
antagonists
human interleukin
interleukin
human
Prior art date
Application number
NO960309A
Other languages
Norwegian (no)
Other versions
NO960309L (en
Inventor
Chuan-Chu Chou
Xia-Yan Cai
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO960309D0 publication Critical patent/NO960309D0/en
Publication of NO960309L publication Critical patent/NO960309L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NO960309A 1993-07-26 1996-01-25 Agonists and antagonists of human interleukin-10 NO960309L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9894393A 1993-07-26 1993-07-26
PCT/US1994/008052 WO1995003411A1 (en) 1993-07-26 1994-07-22 Agonists and antagonists of human interleukin-10

Publications (2)

Publication Number Publication Date
NO960309D0 true NO960309D0 (en) 1996-01-25
NO960309L NO960309L (en) 1996-01-25

Family

ID=22271670

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960309A NO960309L (en) 1993-07-26 1996-01-25 Agonists and antagonists of human interleukin-10

Country Status (17)

Country Link
EP (1) EP0711346A1 (en)
JP (1) JPH08507930A (en)
KR (1) KR960704041A (en)
CN (1) CN1127529A (en)
AU (1) AU681178B2 (en)
CA (1) CA2168110A1 (en)
CZ (1) CZ23396A3 (en)
FI (1) FI960353A (en)
HU (1) HUT73463A (en)
IL (1) IL110413A0 (en)
NO (1) NO960309L (en)
NZ (1) NZ269663A (en)
PL (1) PL312718A1 (en)
SG (1) SG43798A1 (en)
SK (2) SK8396A3 (en)
WO (1) WO1995003411A1 (en)
ZA (1) ZA945434B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220344B (en) 1994-07-05 2001-12-28 Steeno Research Group A/S Immunomodulators
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
AUPN481295A0 (en) * 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
AU4385696A (en) 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
DE19851675A1 (en) * 1998-11-10 2000-05-11 Bayer Ag Human interleukin-10 mutant proteins
KR20020091170A (en) 2000-03-31 2002-12-05 아이덱 파마슈티칼즈 코포레이션 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
US7052686B2 (en) 2000-09-29 2006-05-30 Schering Corporation Pegylated interleukin-10
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
ES2696824T3 (en) 2005-05-31 2019-01-18 Univ Colorado Regents Methods to supply genes
NZ597098A (en) 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
NO2344540T3 (en) 2008-10-02 2018-04-28
HUE037936T2 (en) 2008-12-17 2018-09-28 Merck Sharp & Dohme Mono- and di-peg il-10 production; and uses
DK2776460T3 (en) 2011-11-08 2018-08-06 Umc Utrecht Holding Bv Fusion protein comprising interleukin 4 and interleukin 10
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc Methods of using interleukin-10 for treating diseases and disorders
WO2014176373A2 (en) * 2013-04-24 2014-10-30 Armo Biosciences, Inc. Interleukin-10 compositions and uses thereof
CA2914837A1 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
EP3038642A4 (en) 2013-08-30 2017-01-18 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
JP6660297B2 (en) 2013-11-11 2020-03-11 アルモ・バイオサイエンシーズ・インコーポレイテッド Methods of using interleukin-10 to treat diseases and disorders
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
JP6675394B2 (en) 2014-10-22 2020-04-01 アルモ・バイオサイエンシーズ・インコーポレイテッド Use of interleukin-10 for the treatment of diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
AU2016268403A1 (en) 2015-05-28 2017-12-07 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
EP3341012A4 (en) 2015-08-25 2019-03-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2020212598A1 (en) 2019-04-19 2020-10-22 Synerkine Pharma B.V. A fusion protein comprising il13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01113229A (en) * 1987-10-27 1989-05-01 Inahata Kenkyusho:Kk Porous material of honeycomb structure
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
HU224437B1 (en) * 1991-08-06 2005-09-28 Schering Corp. Process for producing pharmaceutical compositions comprising interleukin-10 analogs or antagonists for treating endotoxin- or superantigen induced toxicity

Also Published As

Publication number Publication date
SG43798A1 (en) 1997-11-14
CN1127529A (en) 1996-07-24
WO1995003411A1 (en) 1995-02-02
AU7399694A (en) 1995-02-20
PL312718A1 (en) 1996-05-13
HU9503983D0 (en) 1996-03-28
FI960353A0 (en) 1996-01-26
ZA945434B (en) 1995-01-23
CZ23396A3 (en) 1996-05-15
FI960353A (en) 1996-01-26
SK8396A3 (en) 1997-03-05
SK150596A3 (en) 1997-04-09
IL110413A0 (en) 1994-10-21
KR960704041A (en) 1996-08-31
AU681178B2 (en) 1997-08-21
NZ269663A (en) 1997-09-22
CA2168110A1 (en) 1995-02-02
HUT73463A (en) 1996-08-28
EP0711346A1 (en) 1996-05-15
JPH08507930A (en) 1996-08-27
NO960309L (en) 1996-01-25

Similar Documents

Publication Publication Date Title
NO960309D0 (en) Agonists and antagonists of human interleukin-10
NO930044D0 (en) PROCEDURE FOR AA EVALUATE FORMS AND DRILLING CONDITIONS
DK609689A (en) FOLIAMINATE AND ITS USE
DK136991A (en) ANIMAL SOMATOTROPIN AND ITS USE
DK535988D0 (en) IMMUNOSUPPRESSIVE PEPTIDES AND METHODS OF USE
DK359686A (en) LYOFILIZED EMULSING AGENTS AND PROCEDURE
DK285388D0 (en) PEPTIME AND ITS USE
NO972477D0 (en) Meso-mono-iodine substituted tetramacrocyclic compounds and methods of preparation and use
EP0450598A3 (en) Inhibitors of the advanced glycosylation of proteins and methods of use therefor
DK183488A (en) FOREIGN DERIVATIVES AND USE THEREOF
IT1241541B (en) PROCEDURE AND DEVICE FOR THE ADDUCTION OF BOTTLES OR SIMILAR
ITMI912840A0 (en) O-FID ANALYSIS EQUIPMENT AND PROCEDURE
IS1813B (en) Use of ferrozene and / or ferrozene derivatives
DK0456138T3 (en) Peptide amidases and their use
DK104890D0 (en) SELF-CORRECTED ANALYSIS EQUIPMENT AND PROCEDURE
DK285288A (en) PEPTIME AND ITS USE
DK584389D0 (en) COMBINATION HERBICIDE AND ITS USE
NO930261D0 (en) TWO-CYCLE LUBRICANT AND PROCEDURE FOR USE
DK296490A (en) PRESERVANT AND USE THEREOF
NO930644D0 (en) ABSORBENT AND USE OF THIS
DK647089D0 (en) CONNECTIONS AND USE
DK624889D0 (en) CONNECTIONS AND USE
IS3269A7 (en) New peptides and their use
ITMI913404A0 (en) PROCEDURE AND MEANS FOR THE CONSTRUCTION OF CONFINED MICROPILES
IS4349A (en) Therapeutic amide and their use